Lipase

Digestive enzyme cartridge

Phase of research

FDA-approved for Cystic Fibrosis

How it helps

Nutritional-GI-Other

General information

Lipase is an enzyme with an essential role in digestion, transport, and processing of dietary lipids. Immobilized lipase cartridge marketed as RELiZORB is indicated for patients to hydrolyze (digest) fats in enteral formula. In relation to cystic fibrosis, our AIM tool found the data that the immobilized lipase cartridge RELiZORB can help improve fatty acids abnormalities in cystic fibrosis patients. By improving omega-3 levels, which has been shown to help pulmonary and inflammatory parameters, it may have long-term therapeutic benefits in patients with cystic fibrosis.

Lipase on Wikipedia

Synonyms

N/A

Marketed as

relizorb - prescribing information

Dietary sources

N/A

C₁₁H₉N₃NaO₂+

Drug-Mutation Relation

results for 1717-1G->A / 4005+1G->A

See all data on Lipase

Treats

Mutation	Link	Tested on	Impact factor	Notes
General effect	Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding.	humans	3.02

Does not treat

Mutation	Link	Tested on	Impact factor	Notes